A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ann Eldred, MD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 94956
Aarhus N, Denmark
- Site Reference Id/investigator# 109295
Copenhagen O, Denmark
- Site Reference Id/investigator# 94955
Odense C, Denmark
- Site Reference Id/investigator# 83739
Danbury, Connecticut, United States
- Site Reference Id/investigator# 87720
Gainesville, Florida, United States
- Site Reference Id/investigator# 83733
Jacksonville, Florida, United States
- Site Reference Id/investigator# 83746
Jacksonville, Florida, United States
- Site Reference Id/investigator# 89178
Tampa, Florida, United States
- Site Reference Id/investigator# 87693
Atlanta, Georgia, United States
- Site Reference Id/investigator# 87717
Augusta, Georgia, United States
- Site Reference Id/investigator# 89180
Fort Wayne, Indiana, United States
- Site Reference Id/investigator# 101942
Indianapolis, Indiana, United States
- Site Reference Id/investigator# 85917
Lexington, Kentucky, United States
- Site Reference Id/investigator# 83732
Bethesda, Maryland, United States
- Site Reference Id/investigator# 83724
Boston, Massachusetts, United States
- Site Reference Id/investigator# 83745
Boston, Massachusetts, United States
- Site Reference Id/investigator# 83750
Grand Blanc, Michigan, United States
- Site Reference Id/investigator# 83747
Petoskey, Michigan, United States
- Site Reference Id/investigator# 83744
Royal Oak, Michigan, United States
- Site Reference Id/investigator# 85913
Saint Paul, Minnesota, United States
- Site Reference Id/investigator# 96455
St Louis, Missouri, United States
- Site Reference Id/investigator# 91253
Omaha, Nebraska, United States
- Site Reference Id/investigator# 93673
Newark, New Jersey, United States
- Site Reference Id/investigator# 83722
New York, New York, United States
- Site Reference Id/investigator# 89176
Asheville, North Carolina, United States
- Site Reference Id/investigator# 83723
Durham, North Carolina, United States
- Site Reference Id/investigator# 92413
Gastonia, North Carolina, United States
- Site Reference Id/investigator# 87733
Winston-Salem, North Carolina, United States
- Site Reference Id/investigator# 83735
Cincinnati, Ohio, United States
- Site Reference Id/investigator# 91813
Columbus, Ohio, United States
- Site Reference Id/investigator# 83738
Toledo, Ohio, United States
- Site Reference Id/investigator# 91693
Portland, Oregon, United States
- Site Reference Id/investigator# 89182
Springfield, Oregon, United States
- Site Reference Id/investigator# 83734
Pittsburgh, Pennsylvania, United States
- Site Reference Id/investigator# 83730
Knoxville, Tennessee, United States
- Site Reference Id/investigator# 101876
Memphis, Tennessee, United States
- Site Reference Id/investigator# 90614
Charlottesville, Virginia, United States
- Site Reference Id/investigator# 83725
Richmond, Virginia, United States
- Site Reference Id/investigator# 87714
Tacoma, Washington, United States
- Site Reference Id/investigator# 91814
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2013
- Primary completion
- 31 Mar 2014
- Completion
- 31 Mar 2014
- Last update posted
- 7 Jul 2021
- Registered enrollment
- 240
- Registry id
- NCT01777165
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.